Carla Ferreira

Carla Ferreira


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2019 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
CFCarla Ferreira
Carla Ferreira
CPCathy Paulino
Cathy Paulino
Alexandre QuintasAlexandre Quintas
Alexandre Quintas


6 July 2020 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
CMCláudia C. Miranda
Cláudia C. Miranda
TBTiago Barata
Tiago Barata
SVSandra H. Vaz
Sandra H. Vaz
CFCarla Ferreira
Carla Ferreira
AQAlexandre Quintas
Alexandre Quintas
EBEvguenia Bekman
Evguenia Bekman
Phytocannabinoids are psychotropic substances ofcannabis with the ability to bind endocannabinoid (eCB) receptors that regulate synaptic activity in the central nervous system (CNS). Synthetic cannabinoids (SCs) are synthetic analogs of Δ9-tetrahydrocannabinol (Δ9-THC), the psychotropic compound of cannabis, acting as agonists of eCB receptor CB1. SC is an easily available and popular alternative to cannabis, and their molecular structure is always changing, increasing the hazard for the general population. The popularity of cannabis and its derivatives may lead, and often does, to a child’s exposure to cannabis both in utero and through breastfeeding by a drug-consuming mother. Prenatal exposure to cannabis has been associated with an altered rate of mental development and significant changes in nervous system functioning. However, the understanding of mechanisms of its action on developing the human CNS is still lacking. We investigated the effect of continuous exposure to cannabinoids on developing human neurons, mimicking the prenatal exposure by drug-consuming mother. Two human induced pluripotent stem cells (hiPSC) lines were induced to differentiate into neuronal cells and exposed for 37 days to cannabidiol (CBD), Δ9-THC, and two SCs, THJ-018 and EG-018. Both Δ9-THC and SC, at 10 μM, promote precocious neuronal and glial differentiation, while CBD at the same concentration is neurotoxic. Neurons exposed to Δ9-THC and SC show abnormal functioning of voltage-gated calcium channels when stimulated by extracellular potassium. In sum, all studied substances have a profound impact on the developing neurons, highlighting the importance of thorough research on the impact of prenatal exposure to natural and SC.

1 March 2022 in Medicines
Verified
Journal Article
Open access
PDF file
BCBeatriz Marques Correia
Beatriz Marques Correia
JFJoana Fernandes
Joana Fernandes
MBMaria João Botica
Maria João Botica
CFCarla Ferreira
Carla Ferreira
Alexandre QuintasAlexandre Quintas
Alexandre Quintas
Background: Novel psychoactive substances (NPS) are compounds of natural and synthetic origin, similar to traditional drugs of abuse. NPS are involved in a contemporary trend whose origin lies in a thinner balance between legitimate therapeutic drug research and legislative control. The contemporary NPS trend resulted from the replacement of MDMA by synthetic cathinones in ‘ecstasy’ during the 2000s. The most common NPS are synthetic cannabinoids and synthetic cathinones. Interestingly, during the last 50 years, these two classes of NPS have been the object of scientific research for a set of health conditions. Methods: Searches were conducted in the online database PubMed using boolean equations. Results: Synthetic cannabinoids displayed protective and therapeutic effects for inflammatory, neurodegenerative and oncologic pathologies, activating the immune system and reducing inflammation. Synthetic cathinones act similarly to amphetamine-type stimulants and can be used for depression and chronic fatigue. Conclusions: Despite the scientific advances in this field of research, pharmacological application of NPS is being jeopardized by fatalities associated with their recreational use. This review addresses the scientific achievements of these two classes of NPS and the toxicological data, ending with a reflection on Illicit and NPS control frames.

11 June 2020 in Life
Verified
Journal Article
Open access
PDF file
CFCarla Ferreira
Carla Ferreira
M. Catarina M.D. De AlmeidaM. Catarina M.D. De Almeida
M. Catarina M.D. De Almeida
Sandra TenreiroSandra Tenreiro
Sandra Tenreiro
Alexandre QuintasAlexandre Quintas
Alexandre Quintas
Parkinson’s Disease (PD) is currently the most rapid growing neurodegenerative disease and over the past generation, its global burden has more than doubled. The onset of PD can arise due to environmental, sporadic or genetic factors. Nevertheless, most PD cases have an unknown etiology. Chemicals, such as the anthropogenic pollutant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and amphetamine-type stimulants, have been associated with the onset of PD. Conversely, cannabinoids have been associated with the treatment of the symptoms’. PD and medical cannabis is currently under the spotlight, and research to find its benefits on PD is on-going worldwide. However, the described clinical applications and safety of pharmacotherapy with cannabis products are yet to be fully supported by scientific evidence. Furthermore, the novel psychoactive substances are currently a popular alternative to classical drugs of abuse, representing an unknown health hazard for young adults who may develop PD later in their lifetime. This review addresses the neurotoxic and neuroprotective impact of illicit substance consumption in PD, presenting clinical evidence and molecular and cellular mechanisms of this association. This research area is utterly important for contemporary society since illicit drugs’ legalization is under discussion which may have consequences both for the onset of PD and for the treatment of its symptoms.

1 May 2019 in Forensic Science International
Verified
Journal Article
Closed access
CFCarla Ferreira
Carla Ferreira
AVAna Rita Vaz
Ana Rita Vaz
PFPedro R. Florindo
Pedro R. Florindo
ÁLÁlvaro Lopes
Álvaro Lopes
Dora BritesDora Brites
Dora Brites
Alexandre QuintasAlexandre Quintas
Alexandre Quintas